Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | +3.09% | 0.00% | -9.09% |
May. 16 | PYC Therapeutics Completes Dosing for Eye Disease Trial; Shares Fall 5% | MT |
May. 09 | Transcript : PYC Therapeutics Limited - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 312M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics' RP11 Investigational Drug Candidate Secures Fast Track Designation from US FDA; Shares Climb 3%